Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

• Published in: Clinical infectious diseases Vol. 25; no. 3; pp. 584 - 599
• Main Authors: Shlaes, David M., Gerding, Dale N., John, Joseph F., Craig, William A., Bornstein, Donald L., Duncan, Robert A., Eckman, Mark R., Farrer, William E., Greene, William H., Lorian, Victor, Levy, Stuart, McGowan, John E., Paul, Sindy M., Ruskin, Joel, Tenover, Fred C., Watanakunakorn, Chatrchai
• Format: Journal Article
• Language: English
• Published: Chicago, IL The University of Chicago Press 01.09.1997; University of Chicago Press
• Subjects: Anti-Bacterial Agents - therapeutic use; Antibacterial agents; Antibiotic resistance; Antibiotics; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antimicrobials; Bacteria; Bacteria - drug effects; Bacteria - genetics; Bacteria - pathogenicity; Bacterial Infections - drug therapy; Bacterial Infections - microbiology; Biological and medical sciences; Cross Infection - microbiology; Cross Infection - prevention & control; Drug Resistance, Microbial - genetics; Epidemiology; Guidelines from the Infectious Diseases Society of America; Hospital administration; Hospitalization; Hospitals; Humans; Infection control; Infections; Medical sciences; Microorganisms; Patient Isolation; Pharmacology. Drug treatments; Recommendations; Societies, Medical; United States; Virulence; United States; North America; America; Sanitary program; Use; Method; Epidemiology; Antimicrobial agent; Recommendation; Prevention; Microorganism resistance; Health policy; Medical prescription; Dissemination; Hospital; National organisation; Sanitary surveillance; Public health
• ISSN: 1058-4838; 1537-6591
• DOI: 10.1086/513766

Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.